Biophytis S.A.
BPTSY
$3.36
$0.4314.68%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.42M | 5.70M | 5.94M | 5.58M | 5.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.20M | 14.39M | 15.50M | 17.10M | 18.57M |
| Operating Income | -13.20M | -14.39M | -15.50M | -17.10M | -18.57M |
| Income Before Tax | -16.31M | -17.41M | -18.41M | -19.47M | -20.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.31 | -17.41 | -18.41 | -19.47 | -20.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.40K | 2.70K | -- | -- | -- |
| Net Income | -16.31M | -17.41M | -18.41M | -19.47M | -20.38M |
| EBIT | -13.20M | -14.39M | -15.50M | -17.10M | -18.57M |
| EBITDA | -12.62M | -13.74M | -14.78M | -16.55M | -18.21M |
| EPS Basic | -7.08 | -11.35 | -15.53 | -24.86 | -34.00 |
| Normalized Basic EPS | -4.64 | -7.06 | -9.43 | -14.51 | -19.48 |
| EPS Diluted | -7.36 | -11.62 | -15.80 | -25.85 | -35.68 |
| Normalized Diluted EPS | -4.64 | -7.06 | -9.43 | -14.51 | -19.48 |
| Average Basic Shares Outstanding | 10.79M | 8.11M | 5.43M | 4.04M | 2.65M |
| Average Diluted Shares Outstanding | 10.79M | 8.11M | 5.43M | 4.04M | 2.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |